glp 1 agonist crohn's disease GLP-1 for Disease: Current Evidence and Treatment Options GLUCAGON-LIKE 1 RECEPTOR AGONIST USE

Early demand for that pill has been stronger than expected, with Novo reporting more than 600,000 prescriptions in March

medRxiv [Preprint] (2020), 2020.09.01.20185850

Diabetes Drugs in the Fight Against Alzheimers Disease

Experts believe that this approach should also guide the selection of medications combined therapy

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover study

This creates a win-win opportunity: Employees get the support they need, and employers can offer a valuable solution without adding pressure to their pharmacy budgets